Aug 10, 2017 23:00 pm UTC| Business
BEVERLY HILLS, Calif., Aug. 10, 2017 -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination and infection prevention company that specializes in disinfection/decontamination sales and...
Mandalay Resources Corporation Announces Second Quarter Financial Results for 2017
Aug 10, 2017 22:24 pm UTC| Business
TORONTO, Aug. 10, 2017 -- Mandalay Resources Corporation ("Mandalay" or the "Company") (TSX:MND) today announced revenue of $44.1 million, adjusted EBITDA of $12.1 million and consolidated net loss of $10.1 million, or...
Aug 10, 2017 22:12 pm UTC| Business
NEW YORK, Aug. 10, 2017 -- Pomerantz LLP announces that a class action lawsuit has been filed against Sequans Communications S.A. (“Sequans” or the “Company”) (NYSE:SQNS) and certain of its officers. The class action,...
Serinus Announces Q2 2017 Financial and Operating Results
Aug 10, 2017 22:10 pm UTC| Business
CALGARY, Alberta, Aug. 10, 2017 -- Serinus Energy Inc. (TSX:SEN) (WARSAW:SEN) (“Serinus”, “SEN” or the “Company”), is pleased to report its financial and operating results for the three months ended June 30, 2017. ...
Aug 10, 2017 22:03 pm UTC| Business
NEW YORK, Aug. 10, 2017 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Ocular Therapeutix, Inc. securities (NASDAQ:OCUL) from May 5, 2017...
YogaWorks, Inc. Announces Pricing of Initial Public Offering
Aug 10, 2017 21:59 pm UTC| Business
CULVER CITY, Calif., Aug. 10, 2017 -- YogaWorks, Inc. (the “Company”), one of the largest and fastest growing providers of high quality yoga instruction in the U.S., today announced the pricing of its initial public...
Aug 10, 2017 21:59 pm UTC| Business
NEW YORK, Aug. 10, 2017 -- Faruqi Faruqi, LLP, a leading national securities law firm, reminds investors in Sequans Communications S.A. (“Sequans” or the “Company”) (NYSE:SQNS) of the October 10, 2017 deadline to seek...
How the US–India tariff truce boosts major Indian industries, Surat to Pharma